Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02013336 |
|---|---|
| Brief Title: | Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors |
| First Submitted : | December 11, 2013 |
| First Submitted that Met QC Criteria : | December 11, 2013 |
| First Posted : | December 17, 2013 (Estimate) |
| Last Update Submitted that Met QC Criteria : | March 17, 2022 |
| Last Update Posted : | March 31, 2022 |